Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001824293-22-000004
Filing Date
2022-02-14
Accepted
2022-02-14 16:15:28
Documents
68
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ck0001824293-20211231.htm   iXBRL 10-K 1469433
2 EX-23.1 vlon-202110k_ex231.htm EX-23.1 4592
3 EX-31.1 vlon-202110k_ex311.htm EX-31.1 10986
4 EX-31.2 vlon-202110k_ex312.htm EX-31.2 10964
5 EX-32.1 vlon-202110k_ex321.htm EX-32.1 5482
6 EX-32.2 vlon-202110k_ex322.htm EX-32.2 5473
  Complete submission text file 0001824293-22-000004.txt   5071644

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck0001824293-20211231.xsd EX-101.SCH 30322
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ck0001824293-20211231_cal.xml EX-101.CAL 53861
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ck0001824293-20211231_def.xml EX-101.DEF 108927
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck0001824293-20211231_lab.xml EX-101.LAB 437474
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck0001824293-20211231_pre.xml EX-101.PRE 276588
62 EXTRACTED XBRL INSTANCE DOCUMENT ck0001824293-20211231_htm.xml XML 532875
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40034 | Film No.: 22632136
SIC: 2834 Pharmaceutical Preparations